Number of patients per prescribed drugs between 2013 and 2022 product image in hero

Number of patients per prescribed drugs between 2013 and 2022

Medical Data Vision
No reviews yetBadge iconVerified Data Provider
製品名
実患者数
金額
xxxxxxxxxx Xxxxxxxxx xxxxxx
xxxxxxxxxx Xxxxx Xxxxxx
Xxxxxxxxxx Xxxxxx Xxxxxxxxx
Xxxxxxxxxx xxxxxxxxx Xxxxxxxxx
xxxxxxxxx Xxxxxxx xxxxxx
Xxxxx xxxxxxxxxx xxxxxx
Xxxxxxxxxx xxxxxx Xxxxx
Xxxxxx xxxxx xxxxxxxx
xxxxxxx Xxxxx Xxxxxxxx
xxxxxxxxxx xxxxxx Xxxxxxxxx
Avail. Formats
.csv, .xls, and .txt
File
Coverage
1
Country

Data Dictionary

[Sample] Data2
Attribute Type Example Mapping
製品名
String 『注』アバスチン
実患者数
String 88,296
金額
String 215,416,071,166

Description

Number of patients treated with prescription medicines by medicine, including calculated revenues based on national health insurance price over the period from January 2013 to December 2022
The dataset, titled "2013年1月ー2022年12月 薬剤患者数," contains essential healthcare information over the ten-year period from January 2013 to December 2022 in Japan. It includes three key fields: 製品名 (Product Name): This field encompasses the names of pharmaceutical products used for medical treatment. These names serve as identifiers for the specific medications or drugs administered to patients. 実患者数 (Actual Number of Patients): This column provides data on the actual count of patients who received treatment with the mentioned pharmaceutical products during the specified timeframe. It serves as a crucial metric for evaluating the prevalence and usage of these medications. 金額 (Amount): The "金額" field represents the monetary value associated with the utilization of these pharmaceutical products. It signifies the total cost or expenditure linked to these medications within the stated period. This dataset is invaluable for various stakeholders within the healthcare industry, including pharmaceutical companies, healthcare providers, researchers, and policymakers. It enables the analysis of trends in medication usage, patient demographics, and associated costs. Researchers can utilize this dataset to conduct pharmacoeconomic studies, assess the impact of specific medications, and make informed decisions regarding healthcare resource allocation. Additionally, pharmaceutical companies can gain insights into the performance of their products in the market. Overall, this dataset facilitates evidence-based decision-making and enhances the understanding of pharmaceutical utilization in Japan from 2013 to 2022.

Country Coverage

Asia (1)
Japan

Pricing

License Starts at
One-off purchase
¥9,000,000 / purchase
Monthly License Not available
Yearly License Not available
Usage-based Not available

Suitable Company Sizes

Small Business
Medium-sized Business
Enterprise

Delivery

Methods
Email
S3 Bucket
SFTP
Frequency
monthly
quarterly
yearly
on-demand
Format
.csv
.xls
.txt

Use Cases

Categories

Related Products

Frequently asked questions

What is Number of patients per prescribed drugs between 2013 and 2022?

Number of patients treated with prescription medicines by medicine, including calculated revenues based on national health insurance price over the period from January 2013 to December 2022

What is Number of patients per prescribed drugs between 2013 and 2022 used for?

This product has 3 key use cases. Medical Data Vision recommends using the data for Competitor Insights, Competitive Intelligence, and Data Driven Marketing. Global businesses and organizations buy Healthcare Marketing Data from Medical Data Vision to fuel their analytics and enrichment.

Who can use Number of patients per prescribed drugs between 2013 and 2022?

This product is best suited if you’re a Medium-sized Business or Enterprise looking for Healthcare Marketing Data. Get in touch with Medical Data Vision to see what their data can do for your business and find out which integrations they provide.

Which countries does Number of patients per prescribed drugs between 2013 and 2022 cover?

This product includes data covering 1 country like Japan. Medical Data Vision is headquartered in Japan.

How much does Number of patients per prescribed drugs between 2013 and 2022 cost?

Pricing for Number of patients per prescribed drugs between 2013 and 2022 starts at JPY9,000,000 per purchase. Connect with Medical Data Vision to get a quote and arrange custom pricing models based on your data requirements.

How can I get Number of patients per prescribed drugs between 2013 and 2022?

Businesses can buy Healthcare Marketing Data from Medical Data Vision and get the data via Email, S3 Bucket, and SFTP. Depending on your data requirements and subscription budget, Medical Data Vision can deliver this product in .csv, .xls, and .txt format.

What is the data quality of Number of patients per prescribed drugs between 2013 and 2022?

You can compare and assess the data quality of Medical Data Vision using Datarade’s data marketplace.

What are similar products to Number of patients per prescribed drugs between 2013 and 2022?

This product has 3 related products. These alternatives include Healthcare Industry Leads Data European Healthcare Sector Verified Hospital & Pharma Leaders Best Price Guarantee, List of the most populated diagnoses in Japan over the past 10 years, and US Healthcare Professionals Data Healthcare Industry Leads: 6.9MM+ Verified Healthcare Contacts. You can compare the best Healthcare Marketing Data providers and products via Datarade’s data marketplace and get the right data for your use case.

Starts at
¥9,000,000 / purchase
License Starts at
One-off purchase
¥9,000,000 / purchase
Monthly License Not available
Yearly License Not available
Usage-based Not available

Medical Data Vision

Developing Better Healthcare Through Utilization of Real-World Data

Verified provider icon Verified Provider
1h Avg. response time
100% Response rate

Trusted by

Customer Logo #1 of Medical Data Vision
Customer Logo #2 of Medical Data Vision
Customer Logo #3 of Medical Data Vision
Promoted

Sync this data product to your data warehouse - no code

Monda makes it easy to access data products from any source and sync them to your preferred data warehouse.